N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol

C168H170ClF19N32O5 — CID 173104941

IUPACN-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol
SMILESCOc1cc2nc(N3CCC(F)(F)CC3)nc(NCc3ccc(F)cc3)c2cc1OC.COc1cc2nc(N3CCCCC3)nc(NCc3ccc(F)cc3)c2cc1OC.FC1(F)CCN(c2nc(NCc3ccc(C(F)(F)F)cc3)nc3ccccc23)CC1.FC1(F)CCN(c2nc(NCc3ccc(Cl)cc3)nc3ccccc23)CC1.Fc1ccc(C2(Nc3nc(N4CCCCC4)nc4ccccc34)CC2)cc1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)c(F)c1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)cc1.OC[C@H](Nc1nc(N2CCCCC2)nc2ccccc12)c1ccccc1
InChIInChI=1S/C22H23F3N4O2.C22H25FN4O2.C22H23FN4.C21H19F5N4.C21H24N4O.C20H19ClF2N4.C20H18F4N4.C20H19F3N4/c1-30-18-11-16-17(12-19(18)31-2)27-21(29-9-7-22(24,25)8-10-29)28-20(16)26-13-14-3-5-15(23)6-4-14;1-28-19-12-17-18(13-20(19)29-2)25-22(27-10-4-3-5-11-27)26-21(17)24-14-15-6-8-16(23)9-7-15;23-17-10-8-16(9-11-17)22(12-13-22)26-20-18-6-2-3-7-19(18)24-21(25-20)27-14-4-1-5-15-27;22-20(23)9-11-30(12-10-20)18-16-3-1-2-4-17(16)28-19(29-18)27-13-14-5-7-15(8-6-14)21(24,25)26;26-15-19(16-9-3-1-4-10-16)22-20-17-11-5-6-12-18(17)23-21(24-20)25-13-7-2-8-14-25;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27;21-14-6-5-13(16(22)11-14)12-25-19-26-17-4-2-1-3-15(17)18(27-19)28-9-7-20(23,24)8-10-28;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27/h3-6,11-12H,7-10,13H2,1-2H3,(H,26,27,28);6-9,12-13H,3-5,10-11,14H2,1-2H3,(H,24,25,26);2-3,6-11H,1,4-5,12-15H2,(H,24,25,26);1-8H,9-13H2,(H,27,28,29);1,3-6,9-12,19,26H,2,7-8,13-15H2,(H,22,23,24);1-8H,9-13H2,(H,24,25,26);1-6,11H,7-10,12H2,(H,25,26,27);1-8H,9-13H2,(H,24,25,26)/t;;;;19-;;;/m....0.../s1
InChIKeySFDPYKHUNOHVAB-AFDKGDPLSA-N
MW3113.84 g/mol
LogP37.65
Rot. Bonds37

About N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol

N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol (PubChem CID 173104941) has the molecular formula C168H170ClF19N32O5 and a molecular weight of 3113.84 g/mol. Its IUPAC name is N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol.

Molecular Properties

Compound NameN-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol
PubChem CID173104941
Molecular FormulaC168H170ClF19N32O5
Molecular Weight3113.84 g/mol
Exact Mass3111.34
IUPAC NameN-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol
SMILESCOc1cc2nc(N3CCC(F)(F)CC3)nc(NCc3ccc(F)cc3)c2cc1OC.COc1cc2nc(N3CCCCC3)nc(NCc3ccc(F)cc3)c2cc1OC.FC1(F)CCN(c2nc(NCc3ccc(C(F)(F)F)cc3)nc3ccccc23)CC1.FC1(F)CCN(c2nc(NCc3ccc(Cl)cc3)nc3ccccc23)CC1.Fc1ccc(C2(Nc3nc(N4CCCCC4)nc4ccccc34)CC2)cc1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)c(F)c1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)cc1.OC[C@H](Nc1nc(N2CCCCC2)nc2ccccc12)c1ccccc1
InChIInChI=1S/C22H23F3N4O2.C22H25FN4O2.C22H23FN4.C21H19F5N4.C21H24N4O.C20H19ClF2N4.C20H18F4N4.C20H19F3N4/c1-30-18-11-16-17(12-19(18)31-2)27-21(29-9-7-22(24,25)8-10-29)28-20(16)26-13-14-3-5-15(23)6-4-14;1-28-19-12-17-18(13-20(19)29-2)25-22(27-10-4-3-5-11-27)26-21(17)24-14-15-6-8-16(23)9-7-15;23-17-10-8-16(9-11-17)22(12-13-22)26-20-18-6-2-3-7-19(18)24-21(25-20)27-14-4-1-5-15-27;22-20(23)9-11-30(12-10-20)18-16-3-1-2-4-17(16)28-19(29-18)27-13-14-5-7-15(8-6-14)21(24,25)26;26-15-19(16-9-3-1-4-10-16)22-20-17-11-5-6-12-18(17)23-21(24-20)25-13-7-2-8-14-25;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27;21-14-6-5-13(16(22)11-14)12-25-19-26-17-4-2-1-3-15(17)18(27-19)28-9-7-20(23,24)8-10-28;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27/h3-6,11-12H,7-10,13H2,1-2H3,(H,26,27,28);6-9,12-13H,3-5,10-11,14H2,1-2H3,(H,24,25,26);2-3,6-11H,1,4-5,12-15H2,(H,24,25,26);1-8H,9-13H2,(H,27,28,29);1,3-6,9-12,19,26H,2,7-8,13-15H2,(H,22,23,24);1-8H,9-13H2,(H,24,25,26);1-6,11H,7-10,12H2,(H,25,26,27);1-8H,9-13H2,(H,24,25,26)/t;;;;19-;;;/m....0.../s1
InChIKeySFDPYKHUNOHVAB-AFDKGDPLSA-N
XLogP37.65
TPSA385.55 Ų
H-Bond Donors9
H-Bond Acceptors37
Rotatable Bonds37
Heavy Atoms225
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003113.84
LogP ≤ 537.65
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1037

Analyze N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol?
The IUPAC name of N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol (CID 173104941) is N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol.
What is the SMILES notation for N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol?
The canonical SMILES for N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol is COc1cc2nc(N3CCC(F)(F)CC3)nc(NCc3ccc(F)cc3)c2cc1OC.COc1cc2nc(N3CCCCC3)nc(NCc3ccc(F)cc3)c2cc1OC.FC1(F)CCN(c2nc(NCc3ccc(C(F)(F)F)cc3)nc3ccccc23)CC1.FC1(F)CCN(c2nc(NCc3ccc(Cl)cc3)nc3ccccc23)CC1.Fc1ccc(C2(Nc3nc(N4CCCCC4)nc4ccccc34)CC2)cc1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)c(F)c1.Fc1ccc(CNc2nc(N3CCC(F)(F)CC3)c3ccccc3n2)cc1.OC[C@H](Nc1nc(N2CCCCC2)nc2ccccc12)c1ccccc1.
What is the InChIKey of N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol?
The InChIKey is SFDPYKHUNOHVAB-AFDKGDPLSA-N. The full InChI is InChI=1S/C22H23F3N4O2.C22H25FN4O2.C22H23FN4.C21H19F5N4.C21H24N4O.C20H19ClF2N4.C20H18F4N4.C20H19F3N4/c1-30-18-11-16-17(12-19(18)31-2)27-21(29-9-7-22(24,25)8-10-29)28-20(16)26-13-14-3-5-15(23)6-4-14;1-28-19-12-17-18(13-20(19)29-2)25-22(27-10-4-3-5-11-27)26-21(17)24-14-15-6-8-16(23)9-7-15;23-17-10-8-16(9-11-17)22(12-13-22)26-20-18-6-2-3-7-19(18)24-21(25-20)27-14-4-1-5-15-27;22-20(23)9-11-30(12-10-20)18-16-3-1-2-4-17(16)28-19(29-18)27-13-14-5-7-15(8-6-14)21(24,25)26;26-15-19(16-9-3-1-4-10-16)22-20-17-11-5-6-12-18(17)23-21(24-20)25-13-7-2-8-14-25;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27;21-14-6-5-13(16(22)11-14)12-25-19-26-17-4-2-1-3-15(17)18(27-19)28-9-7-20(23,24)8-10-28;21-15-7-5-14(6-8-15)13-24-19-25-17-4-2-1-3-16(17)18(26-19)27-11-9-20(22,23)10-12-27/h3-6,11-12H,7-10,13H2,1-2H3,(H,26,27,28);6-9,12-13H,3-5,10-11,14H2,1-2H3,(H,24,25,26);2-3,6-11H,1,4-5,12-15H2,(H,24,25,26);1-8H,9-13H2,(H,27,28,29);1,3-6,9-12,19,26H,2,7-8,13-15H2,(H,22,23,24);1-8H,9-13H2,(H,24,25,26);1-6,11H,7-10,12H2,(H,25,26,27);1-8H,9-13H2,(H,24,25,26)/t;;;;19-;;;/m....0.../s1.
What are the key properties of N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol?
N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol has a molecular weight of 3113.84 g/mol, XLogP of 37.65, 37 rotatable bonds, 9 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;N-[(2,4-difluorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)quinazolin-2-amine;2-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]-6,7-dimethoxyquinazolin-4-amine;4-(4,4-difluoropiperidin-1-yl)-N-[(4-fluorophenyl)methyl]quinazolin-2-amine;4-(4,4-difluoropiperidin-1-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]quinazolin-2-amine;N-[1-(4-fluorophenyl)cyclopropyl]-2-piperidin-1-ylquinazolin-4-amine;N-[(4-fluorophenyl)methyl]-6,7-dimethoxy-2-piperidin-1-ylquinazolin-4-amine;(2R)-2-phenyl-2-[(2-piperidin-1-ylquinazolin-4-yl)amino]ethanol is sourced from PubChem (CID 173104941), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).